Status: Enrolling
Investigator: Alpesh Shah
Study Coordinator: Saba Khan
Phone: 713.441.2116
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions This is a prospective, randomized, single-blind, multi-center trial, conducte ... Read more >
Status: Open Not Enrolling
Investigator: Neal Kleiman
Study Coordinator: Saba Khan
Phone: 713.441.2116
This is a prospective, randomized, parallel-controlled, multicenter clinical evaluation of the MitraClip device for the treatment of clinically significant functional mitral regurgitation in symptomatic subjects too high risk to undergo mitral v ... Read more >
Status: Open Not Enrolling
Investigator: Alpesh Shah
Study Coordinator:
Phone:
This is a prospective, multi-center, non-randomized, single arm clinical trial that will be conducted at up to 40 sites in the United States and OUS. A minimum of 40% of total patients will be enrolled in the US. This study will enroll patient ... Read more >
Status: Open Not Enrolling
Investigator: Neal Kleiman
Study Coordinator:
Phone:
The study is being done study to obtain data on the safety and performance of the Medtronic CoreValve® System. The Medtronic CoreValve® System has been developed to replace a diseased aortic heart valve without the need for open heart surgery. T ... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Patricia Brinegar
Phone: 713.441.3506
The primary objective of the study is to evaluate the safety and effectiveness of the Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme Risk Pivotal Trial population due to one or more additional co-morbidi ... Read more >
Status: Open Not Enrolling
Investigator: Neal Kleiman
Study Coordinator: Patricia Brinegar
Phone: 713.441.3506
To evaluate the safety and efficacy of the CoreValve Evolut R System in patients with severe symptomatic aortic stenosis who are considered at high through extreme risk for surgical aortic valve replacement ... Read more >
Status: Open Not Enrolling
Investigator: Mahendra Jain
Study Coordinator: Bela Jain
Phone: 281.485.3434
To evaluate whether long-term treatment with bempedoic acid 180 mg/day versus placebo reduces the risk of major adverse cardiovascular events (MACE) in patients with, or at high risk for, cardiovascular disease (CVD) who are statin intolerant. ... Read more >
Status: Enrolling
Investigator: Alpesh Shah
Study Coordinator: Saba Khan
Phone: 713.441.2116
The purpose of this study is to determine whether Fractional flow reserve (FFR, (coronary pressure wire-based index for assessing the ischemic potential of a coronary lesion)-guided percutaneous coronary intervention (PCI) in patients with multi ... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Patricia Brinegar
Phone: 713.441.3506
The objective of this study is to evaluate the safety and effectiveness of the Lotus™ Valve System for transcatheter aortic valve replacement (TAVR) in symptomatic subjects with calcific, severe native aortic stenosis who are considered at extre ... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Patricia Brinegar
Phone: 713.441.3506
The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgic ... Read more >
